Jagsonpal Pharmaceuticals

204.96
-4.63
(-2.21%)
ann
There are 3 new updates from the company19 hours ago
Viewcross
right
Market Cap
1,360.22 Cr
EPS
8.49
PE Ratio
38.11
Dividend Yield
0.95 %
Industry
Healthcare
52 Week High
328.04
52 Week low
109.44
PB Ratio
7.04
Debt to Equity
0.04
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,683.45 4,03,916.05 34.10 49,887.20 12.06 9,648 13.77 52.67
5,620.45 1,49,205.29 72.77 8,184.00 0.89 1,600 64.53 45.57
1,461.90 1,18,065.10 23.53 26,520.70 14.17 4,155 47.38 52.92
3,056.05 1,03,430.62 56.27 10,785.70 11.59 1,656 13.54 47.23
1,107.95 92,448.55 17.17 28,905.40 12.36 5,578 1.69 30.37
2,201.15 90,812.16 43.84 10,615.60 19.57 1,942 -16.38 35.15
1,968.45 89,800.21 31.28 20,141.50 19.94 1,936 38.82 43.62
883.10 88,860.52 19.73 19,831.50 13.82 3,831 29.92 40.81
1,094.75 63,583.26 18.24 29,559.20 17.55 3,169 -10.04 43.94
29,597.00 62,891.56 47.49 6,097.20 10.80 1,201 16.01 49.75
Growth Rate
Revenue Growth
-10.07 %
Net Income Growth
-15.73 %
Cash Flow Change
-24.62 %
ROE
-28.72 %
ROCE
-26.33 %
EBITDA Margin (Avg.)
-9.79 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
TTM
Revenue
138
144
144
127
168
161
192
221
242
218
285
Expenses
129
132
138
138
158
150
169
193
203
186
212
EBITDA
9
13
6
-11
11
11
24
29
40
32
73
Operating Profit %
6 %
8 %
4 %
-9 %
6 %
5 %
10 %
12 %
14 %
11 %
15 %
Depreciation
3
3
2
0
1
1
1
2
1
2
6
Interest
5
5
3
1
1
1
1
0
0
1
1
Profit Before Tax
2
4
14
-12
9
9
22
27
35
30
66
Tax
1
1
3
-0
2
2
5
8
8
7
13
Net Profit
1
3
12
-12
7
8
17
19
27
23
52
EPS in ₹
0.45
1.24
4.53
-4.41
2.75
3.00
6.51
7.20
10.20
8.49
12.30

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
154
159
143
130
136
147
164
164
195
217
Fixed Assets
52
52
22
21
22
22
26
23
24
9
Current Assets
96
101
110
95
98
95
121
109
165
199
Capital Work in Progress
0
0
0
3
4
4
0
0
0
0
Investments
0
0
0
0
0
11
15
51
1
0
Other Assets
102
108
121
106
110
109
123
91
170
208
Total Liabilities
154
159
143
130
136
147
164
164
195
217
Current Liabilities
55
57
29
29
28
33
40
27
28
19
Non Current Liabilities
4
4
3
3
3
3
2
5
9
11
Total Equity
95
98
110
98
105
111
122
133
159
187
Reserve & Surplus
82
85
97
85
91
98
109
120
146
174
Share Capital
13
13
13
13
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
2
1
5
-6
24
-1
19
-36
-12
2
Investing Activities
-1
-2
41
-3
-1
-11
-2
-26
-58
-25
Operating Activities
4
9
-3
-2
31
11
28
7
47
35
Financing Activities
-1
-6
-34
-1
-6
-1
-7
-18
-1
-9

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
70.34 %
70.34 %
70.34 %
70.34 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.71 %
68.48 %
68.09 %
68.04 %
67.97 %
67.81 %
FIIs
0.00 %
0.00 %
0.11 %
0.20 %
0.00 %
0.00 %
0.13 %
0.00 %
0.00 %
0.00 %
0.38 %
0.00 %
0.73 %
1.10 %
2.30 %
2.10 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.28 %
0.77 %
0.83 %
0.83 %
0.83 %
0.00 %
0.85 %
0.85 %
0.11 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
26.67 %
26.08 %
23.71 %
23.71 %
22.92 %
25.27 %
22.78 %
21.11 %
22.23 %
22.84 %
21.99 %
21.94 %
20.69 %
20.79 %
20.38 %
20.64 %
Others
2.98 %
3.57 %
5.83 %
5.75 %
8.36 %
6.02 %
8.10 %
9.40 %
8.23 %
7.62 %
8.09 %
9.58 %
9.64 %
9.22 %
9.24 %
9.45 %
No of Share Holders
0
12,546
14,655
14,353
20,031
17,100
16,194
14,952
14,084
13,782
16,041
15,785
16,282
15,748
15,633
18,471

Dividend History

Dividends per share (FY)
Dividend yield (FY) %

No dividends have been distributed by the company in the past 10 years

Corporate Action

Announcements

Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
19 hours ago
Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)
19 hours ago
Appointment of Company Secretary and Compliance Officer
20 hours ago
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
10 days ago
Clarification In Reference To The Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 Dated February 21 2025
Feb 27, 2025, 18:37
Clarification In Reference To The Corporate Announcement Filed Under Regulation 30 Of SEBI (LODR) Regulations 2015 Dated February 21 2025
Feb 27, 2025, 18:37
Announcement under Regulation 30 (LODR)-Acquisition
Feb 21, 2025, 19:36
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR)
Feb 21, 2025, 18:23
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Feb 17, 2025, 10:34
Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI LODR)
Feb 05, 2025, 12:03
Announcement under Regulation 30 (LODR)-Change in Management
Feb 05, 2025, 11:57
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Jan 29, 2025, 13:09
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jan 24, 2025, 15:33
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Jan 23, 2025, 19:06
Integrated Filing (Financial)
Jan 23, 2025, 18:05
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Jan 22, 2025, 19:14
Outcome Of Board Meeting Held On January 22 2025 To Consider And Approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024
Jan 22, 2025, 18:13
Board Meeting Outcome for Outcome Of Board Meeting Held On January 22 2025 To Consider And Approve The Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2024
Jan 22, 2025, 18:03
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Jan 15, 2025, 18:01
Board Meeting Intimation for Intimation Of Board Meeting Under Regulation 29(1) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015
Jan 15, 2025, 17:49
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 03, 2025, 17:49
Closure of Trading Window
Dec 30, 2024, 17:27
Intimation For Record Date For Sub- Division/Split Of Equity Shares Of The Company
Dec 17, 2024, 12:58
Shareholder Meeting / Postal Ballot-Scrutinizers Report
Dec 12, 2024, 17:59
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Dec 06, 2024, 09:39
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)
Nov 22, 2024, 18:25
Update On Intimation As Per Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Sale Of Company''s Faridabad Facility
Nov 19, 2024, 17:58
Announcement Under Regulation 30 - Outcome Of Analyst/Investor Meet
Nov 12, 2024, 16:47
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Nov 12, 2024, 16:40
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 12, 2024, 16:26
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
Nov 11, 2024, 15:52
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
Nov 05, 2024, 22:01
Announcement Under Regulation 30 - Outcome Of Analyst/Investor Meet
Nov 04, 2024, 18:36
Announcement Under Regulation 30 - Outcome Of Analyst/Investor Meet
Nov 04, 2024, 18:31
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Oct 29, 2024, 17:09
Announcement under Regulation 30 (LODR)-Newspaper Publication
Oct 25, 2024, 17:07
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Oct 24, 2024, 16:42
Announcement under Regulation 30 (LODR)-Investor Presentation
Oct 24, 2024, 10:51
Related Party Transaction For The Half Year Ended September 30, 2024
Oct 23, 2024, 19:45
Announcement under Regulation 30 (LODR)-Amendments to Memorandum & Articles of Association
Oct 23, 2024, 18:26
Corporate Action-Intimation of Sub division / Stock Split
Oct 23, 2024, 18:21
Announcement under Regulation 30 (LODR)-Press Release / Media Release
Oct 23, 2024, 18:14
Outcome Of Board Meeting Held On October 23, 2024 & Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements Regulations, 2015
Oct 23, 2024, 18:05
Board Meeting Outcome for Outcome Of Board Meeting Held On October 23, 2024 & Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements Regulations, 2015
Oct 23, 2024, 18:00
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 16, 2024, 20:01
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Oct 16, 2024, 19:51
Board Meeting Intimation for Consider And Approve Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2024.
Oct 16, 2024, 19:42
Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011
Oct 14, 2024, 18:58
Announcement Under Regulation 30 - Receipt Of Settlement Order
Oct 12, 2024, 17:02
Closure of Trading Window
Sep 27, 2024, 17:32

Technical Indicators

RSI(14)
Neutral
40.66
ATR(14)
Less Volatile
14.06
STOCH(9,6)
Neutral
53.77
STOCH RSI(14)
Neutral
38.25
MACD(12,26)
Bearish
-0.09
ADX(14)
Weak Trend
24.41
UO(9)
Bearish
38.81
ROC(12)
Downtrend And Accelerating
-6.68
WillR(14)
Neutral
-72.82